Latest glioblastoma multiforme Stories
Presentations include first Phase 2 results evaluating investigational compound Veliparib in patients with non-small cell lung cancer NORTH CHICAGO, Ill., Sept.
ICT-107 Phase II Update Selected for Oral Presentation at Society for Neuro-Oncology Meeting in November; ICT-121 and ICT-140 Programs on Track LOS ANGELES, Sept.
BETHESDA, Md., Sept. 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
SAN ANTONIO, Sept. 9, 2014 /PRNewswire/ -- GenSpera, Inc.
BETHESDA, Md., Sept.
50% of Patients Treated with Mipsagargin had No Tumor Growth at Four Months SAN ANTONIO, Sept. 8, 2014 /PRNewswire/ -- GenSpera, Inc.
Research takes another step closer to clinical trials. Chicago, IL (PRWEB) September 04, 2014 The American Brain Tumor Association (ABTA) Discovery Grant
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept.
Designation of High Unmet Medical Need allows for accelerated review of regulatory submissions in Japan, the second largest medical device market in the world ST.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.